Eating a healthy diet far outweighs the potential benefits of taking a supplement, experts say, and yet we have a whole industry based on selling us all types of products. Here's when to take one, after consulting with your doctor, and when to pass. More
Now they are using lessons from the experience to urge action on the growing problem of drug-resistant infections before it’s too late. More
There's no evidence that a daily aspirin should be taken by most adults in good cardiovascular health, according to a new review. The risk of a major bleeding event due to the drug's blood thinning effects outweighs the benefit, the research said. More
New details emerge in a lawsuit asserting that chains including CVS, Rite Aid and Walgreens sold millions of pills in small towns but rarely flagged suspicious orders to authorities. More
As coronavirus health concerns, social isolation and job-loss stress take a toll, people turn to medications; “It can very quickly become a habit.” More
Remdesivir is the poster child for why we need a new model of drug development for pandemics and neglected diseases that isn't market-based. More
The saga of the drugs’ rise and fall in Utah provides a case study of what happens when hope and excitement about therapies outpace the evidence. More
Between 2016 and 2019, the United States experienced a rapid proliferation of limits restricting the duration or number of doses in opioid prescriptions for acute pain.1 As of October 2019, such limits have been enacted by 34 states; large payers, such as Medicare, several state Medicaid programs, Aetna, and UnitedHealth; pharmacy chains, such as Sam’s Club/Walmart; and major pharmacy benefit managers, such as CVS CareMark, ExpressScripts, and OptumRx, which collectively manage drug benefits for 180 million Americans. More
Two studies show promise, but physicians have more questions than answers about the data. More
Because the public is getting so many mixed messages from politicians, health experts, researchers, and the news media, it’s our responsibility as journalists to provide clarity and moderate optimism. More